Biocon arm gets USFDA nod for cancer, deep vein thrombosis drugs Ruchika Sharma5 March 2025 11:30 AM ISTBangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received final approvals...
Sanofi Sarclisa combo gets Japanese nod for newly diagnosed multiple myeloma Ruchika Sharma27 Feb 2025 11:30 AM ISTParis: Sanofi has announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Sarclisa, in combination with...
Dr Reddy's Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, Europe Ruchika Sharma7 Feb 2025 1:30 PM ISTHyderabad: Dr Reddy's Laboratories SA, a wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd. has announced that it has entered into a ...
Sanofi Sarclisa approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Ruchika Sharma2 Feb 2025 10:45 AM ISTParis: Sanofi has announced that the National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a...
Sanofi Sarclisa approved in EU for newly diagnosed multiple myeloma Ruchika Sharma26 Jan 2025 1:30 PM ISTParis: Following the adoption of a positive opinion by the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use...
Sanofi Sarclisa gains Chinese nod for treatment of adult patients with relapsed or refractory multiple myeloma Ruchika Sharma14 Jan 2025 1:30 PM ISTParis: Sanofi has announced that the National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine,...
Doctors at Delhi AIIMS Developing Low-cost Adaptive Cellular Therapy for Multiple Myeloma Kajal Rajput25 Dec 2024 5:00 PM ISTNew Delhi: Doctors at the premier health institute, the All India Institute of Medical Sciences AIIMS Delhi are working on an...
Fiber diet may delay a type of blood cancer, reveals research Dr. Kamal Kant Kohli11 Dec 2024 8:45 PM ISTToday researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from the first ever clinical trial to show that a high fiber plant...
Blenrep combo accepted for priority review in China in relapsed/refractory multiple myeloma: GSK Ruchika Sharma11 Dec 2024 1:30 PM ISTLondon: GSK plc has announced that the National Medical Products Administration (NMPA) of China has accepted for review a new drug application...
USFDA accepts for review application for GSK Blenrep combinations for multiple myeloma treatment Ruchika Sharma26 Nov 2024 5:52 PM ISTLondon: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for...
Sarclisa recommended for EU approval by CHMP to treat transplant-ineligible newly diagnosed multiple myeloma: Sanofi Ruchika Sharma17 Nov 2024 4:00 PM ISTParis: Sanofi has announced that the European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) has adopted a...
JnJ seeks approval from USFDA, EMA for DARZALEX FASPRO as subcutaneous monotherapy for high-risk smoldering multiple myeloma Ruchika Sharma10 Nov 2024 4:15 PM ISTRaritan: Johnson & Johnson has announced the submission of regulatory applications to the U.S. Food and Drug Administration (FDA) and...
